Inhibition of mitochondrial reactive oxygen species improves coronary endothelial function after cardioplegic hypoxia/reoxygenation.

MLA

Song, Yi, et al. “Inhibition of Mitochondrial Reactive Oxygen Species Improves Coronary Endothelial Function after Cardioplegic Hypoxia/Reoxygenation.” The Journal of Thoracic and Cardiovascular Surgery, vol. 164, no. 5, Nov. 2022, pp. e207–26. EBSCOhost, https://doi.org/10.1016/j.jtcvs.2021.06.029.

APA

Song, Y., Xing, H., He, Y., Zhang, Z., Shi, G., Wu, S., Liu, Y., Harrington, E. O., Sellke, F. W., & Feng, J. (2022). Inhibition of mitochondrial reactive oxygen species improves coronary endothelial function after cardioplegic hypoxia/reoxygenation. The Journal of Thoracic and Cardiovascular Surgery, 164(5), e207–e226. https://doi.org/10.1016/j.jtcvs.2021.06.029

Chicago

Song, Yi, Hang Xing, Yixin He, Zhiqi Zhang, Guangbin Shi, Su Wu, Yuhong Liu, Elizabeth O Harrington, Frank W Sellke, and Jun Feng. 2022. “Inhibition of Mitochondrial Reactive Oxygen Species Improves Coronary Endothelial Function after Cardioplegic Hypoxia/Reoxygenation.” The Journal of Thoracic and Cardiovascular Surgery 164 (5): e207–26. doi:10.1016/j.jtcvs.2021.06.029.